Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma

Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma

Saved in:

Bibliographic Details
Main Authors:	Ahmed H. Al Sharie, Samah O. Al-Omari, Abdelwahab Aleshawi, Rami Al-Dwairi, Osama Al Deyabat
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Oncology
Subjects:	uveal melanoma chimeric antigen receptor t cells therapy CAR-T preclinical studies clinical trials and immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1555842/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases
by: Isidora Protić-Rosić, et al.
Published: (2025-05-01)

Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases
by: Mingwei Jiang, et al.
Published: (2025-12-01)

MUC18-Directed chimeric antigen receptor T cells for the treatment of mucosal melanoma
by: Fenghao Zhang, et al.
Published: (2025-04-01)

Global incidence and prevalence in uveal melanoma
by: Xincen Hou, et al.
Published: (2024-11-01)

Current Therapies and Potential Strategies for Uveal Melanoma
by: Sarah Scoles, et al.
Published: (2025-04-01)

The correlation between uveal melanoma and iris nevus
by: Yuhang Yang, et al.
Published: (2024-12-01)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01)

Circulating tumor DNA. Modern views about the possibility of use in uveal melanoma
by: A. M. Bogatyrev, et al.
Published: (2025-03-01)

Surgical Management Of Liver Metastases From Uveal Melanoma
by: Ulaș Sözener, et al.
Published: (2015-04-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01)

Direct visualization of chimeric antigen receptors on primary human T cells using dSTORM super-resolution microscopy
by: Leon Gehrke, et al.
Published: (2025-08-01)

Construction of immune-related risk signature for uveal melanoma
by: Zhaotian Zhang, et al.
Published: (2020-01-01)

Remodeling of the extracellular matrix in human uveal melanoma
by: А.Yu. Shatruk, et al.
Published: (2024-09-01)

Аngiogenesis in Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-10-01)

Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study
by: Lucille Vitek, et al.
Published: (2024-12-01)

Melanoma uveal primario a propósito de un caso
by: Alejandro Jarol Pavón Rojas, et al.
Published: (2025-06-01)

Omental metastases from uveal melanoma—An interesting intraoperative omental pattern appearance
by: Sofoklis Stavros, et al.
Published: (2024-09-01)

Surgical treatment of uveal melanoma: Exoresection versus endoresection
by: Seung Min Lee, et al.
Published: (2025-01-01)

Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy
by: Jia-Hui Liu, et al.
Published: (2025-05-01)

Current trials in uveal melanoma: Three promising treatments tested to prevent or mitigate the effects of radiation
by: Yehonatan Weinberger, et al.
Published: (2025-01-01)

Immunohistochemical analysis of prame expression as a prognostic factor in uveal melanoma patients
by: S. V. Saakyan, et al.
Published: (2021-12-01)

Identification of diagnostic and prognostic genetic alterations in uveal melanoma using RNA sequencing
by: Rogier J. Nell, et al.
Published: (2025-03-01)

Research advances of matrix metalloproteinases family in uveal melanoma
by: Yuning Chen, et al.
Published: (2025-07-01)

Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies
by: Xiaoshuang Yuan, et al.
Published: (2025-05-01)

Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
by: Gohar S. Manzar, et al.
Published: (2025-01-01)

PRIMARY ENDOPROSTHETIC REPLACEMENT OF THE ANOPHTHALMIC ORBIT IN PATIENTS WITH UVEAL MELANOMA: SIX-YEAR FOLLOW-UP RESULTS
by: A. A. Yarovoy, et al.
Published: (2015-04-01)

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
by: Michele Massimino, et al.
Published: (2025-01-01)

A 39‐Year Nationwide Study of Uveal Melanoma in Taiwan
by: An‐Ning Chao, et al.
Published: (2025-04-01)

Expression of Vascular Endothelial Growth Factor in Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-12-01)

ANALYSIS OF METASTASES AND SURVIVAL RATES IN PATIENTS WITH UVEAL MELANOMA
by: S. V. Saakyan, et al.
Published: (2015-04-01)

Uveal effusion syndrome (clinical case)
by: Yu. A. Belyy, et al.
Published: (2015-10-01)

The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01)

Contralateral eyelid metastasis of uveal melanoma with further systemic dissemination
by: Bobić-Radovanović Anica, et al.
Published: (2010-01-01)

Immunohistochemical study of uveal melanoma and its cellular microenvironment
by: S. V. Saakyan, et al.
Published: (2022-06-01)

Liquid Biopsy for Uveal Melanoma. Does It Make Sense?
by: V. E. Ovanesyan, et al.
Published: (2022-10-01)

Uveal melanoma following Bruton's tyrosine inhibitor use for the treatment of hematologic malignancies
by: Tara Murty, et al.
Published: (2025-06-01)

Clinical and morphological aspects of the development of secondary ophthalmic hypertension in uveal melanoma
by: E. E. Grishina, et al.
Published: (2022-07-01)

Uveal Melanoma and its Various Presentations – A Series of Case Reports
by: Sujit Das
Published: (2024-12-01)

Proton therapy for uveal melanoma (preliminary results)
by: I.E. Panova, et al.
Published: (2023-11-01)

A cohort of long-surviving patients affected by small and medium uveal melanoma treated with ruthenium-106 plaque brachytherapy
by: Concetta Laliscia, et al.
Published: (2025-01-01)